Pharmaxis Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaxis Ltd with three other companies in this sector in Australia: Benitec Biopharma Limited (2019 sales of 16.60 million Australian Dollars [US$11.46 million] ), Cellmid Limited (7.47 million Australian Dollars [US$5.15 million] ), and Idt Australia Limited. (12.13 million Australian Dollars [US$8.37 million] ).

Sales Analysis. Sales fell dramatically in 2019: During the year ended June of 2019, sales at Pharmaxis Ltd were A$12.55 million (US$8.66 million). This is a sharp decrease of 75.1% versus 2018, when the company's sales were A$50.33 million.